Coming Up On #SantoAndCJ
RIL's stock has fallen considerably in the past few sessions but has found support at a crucial level.
Watch CJ explain why he believes that the #RIL's #stock is gearing up for another uptrend in the coming weeks. Santo, on the other hand, is worried for #TorrentPharma's prospects after a rather expensive shopping bill but CJ sees chances of a recovery.
🔴 Tunein at 3 PM 🕒 https://www.youtube.com/watch?v=q0YVLNR7hdw
RIL's stock has fallen considerably in the past few sessions but has found support at a crucial level.
Watch CJ explain why he believes that the #RIL's #stock is gearing up for another uptrend in the coming weeks. Santo, on the other hand, is worried for #TorrentPharma's prospects after a rather expensive shopping bill but CJ sees chances of a recovery.
🔴 Tunein at 3 PM 🕒 https://www.youtube.com/watch?v=q0YVLNR7hdw
#ShareKhan predicts in-line to marginal outperformance for the #pharma index going forward as valuations have become reasonable for large players such as #SunPharma, #ZydusLife, Dr Reddy’s and #TorrentPharma, as well as for niche India-focused players such as #AbbottIndia.
Read Here 👇🏻
https://bit.ly/3KDMb8m
Read Here 👇🏻
https://bit.ly/3KDMb8m
Moneycontrol
ShareKhan has a 'neutral' stance on pharma companies; here's why
The brokerage firm has given 'buy' or 'hold' calls to 13 out of the total 16 companies in its pharmaceutical coverage